SOPHiA GENETICS (SOPH) EBT (2020 - 2025)

SOPHiA GENETICS has disclosed EBT across 6 years of filings, most recently posting -$19.6 million for Q4 2025.

• EBT for Q4 2025 came in at -$19.6 million, down 34.6% year-over-year; the trailing twelve-month figure through Dec 2025 was -$77.5 million (down 26.47% YoY), and the FY2025 annual result was -$77.5 million, down 26.47% from the prior year.
• EBT came in at -$19.6 million for Q4 2025 at SOPHiA GENETICS, down from -$19.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$12.5 million in Q1 2021 to a low of -$25.3 million in Q1 2022.
• The 5-year median for EBT is -$19.5 million (2025), against an average of -$18.9 million.
• Across the five-year window, EBT jumped 99.8% in 2021 and plunged 102.15% in 2022, its largest moves.
• SOPHiA GENETICS's EBT stood at -$21.9 million in 2021, then jumped by 35.03% to -$14.2 million in 2022, then plunged by 69.05% to -$24.1 million in 2023, then surged by 39.54% to -$14.5 million in 2024, then sank by 34.6% to -$19.6 million in 2025.
• The last three EBT figures came in at -$19.6 million (Q4 2025), -$19.4 million (Q3 2025), and -$21.7 million (Q2 2025), per Business Quant data.